NPI Details
PROTEUS MOLECULAR AND CLINICAL LAB LLC is a clinical medical laboratory in Homewood, AL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PROTEUS MOLECULAR AND CLINICAL LAB LLC NPI is 1538542196. The provider is registered as an organization entity type.
The provider Is Doing Business As Proteus Lab.
The provider's business location address is:
218 SUMMIT PKWY
SUITE 250
HOMEWOOD, AL
ZIP 35209
Phone: (205) 820-0115
The provider's authorized official is Michael A Griffith .
The authorized official title is Member Manager and has the following contact phone number (205) 820-0115.
The CLIA number assigned to this NPI record is 01D2098265 - independent with a certificate type of Certificate of Compliance.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
- Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled (HCPCS:P9603)
- Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
- Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
- Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
- Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
- Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
- Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
- Automated urinalysis test (HCPCS:81003)
- Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
- Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique (HCPCS:87634)
- Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
- Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
- Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
- Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique (HCPCS:87498)
- Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
- Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
- Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
- Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
The enumeration date for this NPI number is 7/1/2015 and was last updated on 6/18/2018.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 291U00000X | Clinical Medical Laboratory | | | ALABAMA | Yes |
Other Identifiers
The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.
| No. |
Other Provider Identifier |
Other Provider Identifier Type |
Other Provider Identifier State |
Other Provider Identifier Issuer |
| 1 | 198878 | MEDICAID | ALABAMA | |
